These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions. Serrano B; de Sanjosé S; Tous S; Quiros B; Muñoz N; Bosch X; Alemany L Eur J Cancer; 2015 Sep; 51(13):1732-41. PubMed ID: 26121913 [TBL] [Abstract][Full Text] [Related]
3. Anogenital intraepithelial lesions in HIV positive patients. Report of 3 cases with 3-year follow-up. Makris N; Xygakis A; Sakellaropoulos G; Iatrakis G; Ladopoulos J Eur J Gynaecol Oncol; 1999; 20(4):321-2. PubMed ID: 10475133 [TBL] [Abstract][Full Text] [Related]
4. Chapter 17: Genital human papillomavirus infections--current and prospective therapies. Stanley M J Natl Cancer Inst Monogr; 2003; (31):117-24. PubMed ID: 12807955 [TBL] [Abstract][Full Text] [Related]
5. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. Sellors JW; Lorincz AT; Mahony JB; Mielzynska I; Lytwyn A; Roth P; Howard M; Chong S; Daya D; Chapman W; Chernesky M CMAJ; 2000 Sep; 163(5):513-8. PubMed ID: 11006761 [TBL] [Abstract][Full Text] [Related]
6. EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease. Arbyn M; de Sanjosé S; Saraiya M; Sideri M; Palefsky J; Lacey C; Gillison M; Bruni L; Ronco G; Wentzensen N; Brotherton J; Qiao YL; Denny L; Bornstein J; Abramowitz L; Giuliano A; Tommasino M; Monsonego J Int J Cancer; 2012 Nov; 131(9):1969-82. PubMed ID: 22623137 [TBL] [Abstract][Full Text] [Related]
7. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. Muñoz N; Kjaer SK; Sigurdsson K; Iversen OE; Hernandez-Avila M; Wheeler CM; Perez G; Brown DR; Koutsky LA; Tay EH; Garcia PJ; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Steben M; Bosch FX; Dillner J; Huh WK; Joura EA; Kurman RJ; Majewski S; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan JT; Lupinacci LC; Giacoletti KE; Sings HL; James MK; Hesley TM; Barr E; Haupt RM J Natl Cancer Inst; 2010 Mar; 102(5):325-39. PubMed ID: 20139221 [TBL] [Abstract][Full Text] [Related]
8. Role of the human papilloma virus in the development of cervical intraepithelial neoplasia and malignancy. Jastreboff AM; Cymet T Postgrad Med J; 2002 Apr; 78(918):225-8. PubMed ID: 11930025 [TBL] [Abstract][Full Text] [Related]
9. Cancers attributable to human papillomavirus infection. Grulich AE; Jin F; Conway EL; Stein AN; Hocking J Sex Health; 2010 Sep; 7(3):244-52. PubMed ID: 20719211 [TBL] [Abstract][Full Text] [Related]
10. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. Wright TC; Denny L; Kuhn L; Pollack A; Lorincz A JAMA; 2000 Jan; 283(1):81-6. PubMed ID: 10632284 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic HPV vaccines. Hancock G; Hellner K; Dorrell L Best Pract Res Clin Obstet Gynaecol; 2018 Feb; 47():59-72. PubMed ID: 29108943 [TBL] [Abstract][Full Text] [Related]
12. Pap smears for men: a vision of the future? Oon SF; Hanly A; Winter DC Ir J Med Sci; 2010 Sep; 179(3):459-62. PubMed ID: 19763675 [TBL] [Abstract][Full Text] [Related]
13. Prevention and control of neoplasms associated with HPV in high-risk groups in Mexico City: The Condesa Study. Lazcano-Ponce E; Salmerón J; González A; Allen-Leigh B; León-Maldonado L; Magis C; Aranda-Flores C; Conde-González C; Portillo-Romero AJ; Yunes-Díaz E; Rivera-Rivera L; Vargas G; Nyitray AG; Giuliano AR Salud Publica Mex; 2018; 60(6):703-712. PubMed ID: 30699275 [TBL] [Abstract][Full Text] [Related]
14. Anal cancer in renal transplant patients. Patel HS; Silver AR; Northover JM Int J Colorectal Dis; 2007 Jan; 22(1):1-5. PubMed ID: 16133005 [TBL] [Abstract][Full Text] [Related]
15. Clinical performance of hybrid capture 2 human papillomavirus testing for recurrent high-grade cervical/vaginal intraepithelial neoplasm in patients with an ASC-US Papanicolaou test result during long-term posttherapy follow-up monitoring. De Vivar AD; Dawlett M; Wang JP; Jack A; Gong Y; Staerkel G; Guo M Arch Pathol Lab Med; 2015 Feb; 139(2):219-24. PubMed ID: 25611104 [TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. Naucler P; Ryd W; Törnberg S; Strand A; Wadell G; Elfgren K; Rådberg T; Strander B; Johansson B; Forslund O; Hansson BG; Rylander E; Dillner J N Engl J Med; 2007 Oct; 357(16):1589-97. PubMed ID: 17942872 [TBL] [Abstract][Full Text] [Related]
18. A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions. Kjaer SK; Sigurdsson K; Iversen OE; Hernandez-Avila M; Wheeler CM; Perez G; Brown DR; Koutsky LA; Tay EH; García P; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Lehtinen M; Steben M; Bosch FX; Dillner J; Joura EA; Majewski S; Muñoz N; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan J; Maansson R; Lu S; Vuocolo S; Hesley TM; Saah A; Barr E; Haupt RM Cancer Prev Res (Phila); 2009 Oct; 2(10):868-78. PubMed ID: 19789295 [TBL] [Abstract][Full Text] [Related]
19. Molecular pathogenesis of cervical cancer. Ibeanu OA Cancer Biol Ther; 2011 Feb; 11(3):295-306. PubMed ID: 21239888 [TBL] [Abstract][Full Text] [Related]
20. The Human Papillomavirus Vaccine: Current Perspective and Future Role in Prevention and Treatment of Anal Intraepithelial Neoplasia and Anal Cancer. Mensah FA; Mehta MR; Lewis JS; Lockhart AC Oncologist; 2016 Apr; 21(4):453-60. PubMed ID: 26961923 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]